CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-04). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2143 · Search date 2026-08-04 · Methodology v0.6

Caffeinated coffee, at least 600 mL/day,
does it really help with Prevention of incident clinical depression?

30-Second Summary
C
Evidence Grade C · 52 · Safety caution
Lagged analyses pointed the same way, but this was not a depression-prevention trial
High caffeine intake may worsen insomnia or anxiety; people with anxiety, sleep problems, or caffeine sensitivity should use caution.
What the
research shows
The grade is C. Among 50,739 women free of depression or severe symptoms and followed for 10 years, at least four cups/day was associated with RR 0.80 (95% CI 0.64 to 0.99) versus at most one cup/week. The outcome relied on self-reported diagnosis and antidepressant use, and predisposition to depression may have reduced coffee intake first.
What the
ads claim
The fact that coffee contains caffeine and the observed lower depression incidence must be separated. Verdict 119 is A with 88 points for acute alertness and performance, but that cannot be extended to long-term depression prevention.
*

Useful facts when choosing a product

  • One cup was 150 mL, making four cups at least 600 mL.
  • Mean total dietary caffeine in the highest group was 649±220 mg/day and included all dietary sources, not coffee alone.
  • Brewing method and measured caffeine per cup were not reported.
Gap Measurement · Verdict 2143 · C 52
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Nurses' Health Study followed 50,739 women from 1996 to 2006. The reference was at most one caffeinated cup per week, not strict lifelong abstention. One cup was 150 mL. Mean total dietary caffeine in the highest group was 649 mg/day and included noncoffee sources. Smoking was adjusted as never, past, or current; association was stronger in current smokers, interaction P=.06. NIH and nonprofit funding were confirmed.

02

Why this is classified as C (52)

A significant incident-outcome association and lag analyses are offset by self-reported outcomes, major selection, and residual reverse causation, giving C with 52 points.

Counterpoint. Repeated questionnaires and an eight-year lag are stronger than cross-sectional evidence.

Rejudgment record. Cross-check applied — A significant association with incident clinical depression remained limited by self-reported outcomes, selection, and residual reverse causation

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced incident clinical depression in womenCDirection persisted with an eight-year lag, but evidence remained observational.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Prospective female cohort2,607NIH DK58845, NARSAD, and a Quebec research fellowshipIncident clinical depression over 10 yearsAt least four cups/day versus at most one/week: RR 0.80 (0.64-0.99)Core long-term observational evidence
Study 2Two-sample Mendelian randomizationAcademic research supportDepressionGenetically predicted coffee consumption OR 0.89 (0.66-1.21)Lifelong-exposure cross-check; null
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-04).

Lucas M, Mirzaei F, Pan A, et al. Coffee, Caffeine, and Risk of Depression Among Women. Arch Intern Med. 2011;171:1571-1578. PMID: 21949167. DOI: 10.1001/archinternmed.2011.393.
checked
Kwok MK, Leung GM, Schooling CM. Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study. Sci Rep. 2016;6:36500. PMID: 27845333. DOI: 10.1038/srep36500.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none

Cite this verdict

Caffeinated coffee, at least 600 mL/day x prevention of incident depression Evidence Grade C card
[Chamgap] Caffeinated coffee, at least 600 mL/day x prevention of incident depression — Evidence Grade C·52. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/mood/caffeinated-coffee-600-ml-incident-depression-prevention/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.